| [1] |
GAO Xu, PENG Jin’e, FAN Zibo, ZHANG Wei.
Systematic evaluation of clinical features and prognostic outcomes of rifampicin-induced hemolytic anemia
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 671-676.
|
| [2] |
.
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(12): 767-767.
|
| [3] |
SHI Fu-guo, GU Ming, MA Shi-ping.
Literature Analysis on the Characteristic of Distribution of Adverse Drug Reactions Induced by Main First-line Antituberculosis Drugs
[J]. Chinese Journal of Pharmacovigilance, 2011, 8(7): 434-437.
|
| [4] |
FENG Hong-yun, CHEN Yi-xin.
Analysis on 4750 Adverse Drug Reaction Cases of Anti-tuberculosis Drugs
[J]. Chinese Journal of Pharmacovigilance, 2010, 7(12): 751-754.
|
